2-acetylaminofluorene has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, JJ | 1 |
| Yao, M | 1 |
| Yang, J | 1 |
| Cai, Y | 1 |
| Zheng, WJ | 1 |
| Wang, L | 1 |
| Yao, DB | 1 |
| Yao, DF | 1 |
1 other study available for 2-acetylaminofluorene and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis.
Topics: 2-Acetylaminofluorene; Alanine Transaminase; Animals; Aspartate Aminotransferases; Carcinogenesis; C | 2017 |